{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:59:28Z","timestamp":1781704768491,"version":"3.54.5"},"reference-count":15,"publisher":"Norwegian Medical Association","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"DOI":"10.4045\/tidsskr.18.0752","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T02:20:18Z","timestamp":1566440418000},"source":"Crossref","is-referenced-by-count":1,"title":["T\u00f8rre \u00f8yne \u2013 diagnostikk og behandling"],"prefix":"10.4045","volume":"139","author":[{"given":"Sten","family":"R\u00e6der","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Klyve","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tor Paaske","family":"Utheim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","published-online":{"date-parts":[[2019,8,8]]},"reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"2007 Report of the International Dry Eye WorkShop (DEWS). Ocul Surf 2007; 5: 65\u2013204.","DOI":"10.1016\/S1542-0124(12)70076-9"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"Nichols\u00a0KK, Foulks\u00a0GN, Bron\u00a0AJ et al. The international workshop on meibomian gland dysfunction: executive summary. Invest Ophthalmol Vis Sci 2011; 52: 1922\u20139. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21450913&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1167%2Fiovs.10-6997a","DOI":"10.1167\/iovs.10-6997a"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"Craig\u00a0JP, Nelson\u00a0JD, Azar\u00a0DT et al. TFOS DEWS II Report Executive Summary. Ocul Surf 2017; 15: 802\u201312. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=28797892&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.jtos.2017.08.003","DOI":"10.1016\/j.jtos.2017.08.003"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"Rhee\u00a0MK, Mah\u00a0FS. Inflammation in dry eye disease: How do we break the cycle? Ophthalmology 2017; 124: S14\u20139. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=29055357&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.ophtha.2017.08.029","DOI":"10.1016\/j.ophtha.2017.08.029"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"Sjogren\u00a0H. Zur Kenntnis der Keratoconjunctivitis Sicca. Acta Ophthalmol 1938; 16: 70\u20139.","DOI":"10.1111\/j.1755-3768.1938.tb04739.x"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Craig\u00a0JP, Nelson\u00a0JD, Azar\u00a0DT et al. TFOS DEWS II Report Epidemiology Summary. Ocul Surf 2017; 15: 802\u201312. Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.jtos.2017.08.003","DOI":"10.1016\/j.jtos.2017.08.003"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Buchholz\u00a0P, Steeds\u00a0CS, Stern\u00a0LS et al. Utility assessment to measure the impact of dry eye disease. Ocul Surf 2006; 4: 155\u201361. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16900272&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2FS1542-0124(12)70043-5","DOI":"10.1016\/S1542-0124(12)70043-5"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"Miljanovi\u0107\u00a0B, Dana\u00a0R, Sullivan\u00a0DA et al. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol 2007; 143: 409\u201315. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17317388&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.ajo.2006.11.060","DOI":"10.1016\/j.ajo.2006.11.060"},{"key":"ref=9","unstructured":"Bron\u00a0AJ, de Paiva\u00a0CS, Chauhan\u00a0SK et al. TFOS DEWS II pathophysiology report. Ocul Surf 2017; 15: 438\u2013510. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=28736340&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.jtos.2017.05.011"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"Jones\u00a0L, Downie\u00a0LE, Korb\u00a0D et al. TFOS DEWS II Management and Therapy Report. Ocul Surf 2017; 15: 575\u2013628. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=28736343&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.jtos.2017.05.006","DOI":"10.1016\/j.jtos.2017.05.006"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007; 5: 163\u201378. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17508120&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2FS1542-0124(12)70085-X","DOI":"10.1016\/S1542-0124(12)70085-X"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"Geerling\u00a0G, Tauber\u00a0J, Baudouin\u00a0C et al. The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci 2011; 52: 2050\u201364. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21450919&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1167%2Fiovs.10-6997g","DOI":"10.1167\/iovs.10-6997g"},{"key":"ref=13","unstructured":"Heegaard S, Loumann Knudsen L, van Setten G et al. Nordic Guidelines 2016. Dry Eye Disease. K\u00f8benhavn: Dansk Oftalmologisk Selskab, 2016."},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"Adil\u00a0MY, Xiao\u00a0J, Olafsson\u00a0J et al. Meibomian gland morphology is a sensitive early indicator of meibomian gland dysfunction. Am J Ophthalmol 2019; 200: 16\u201325. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=30578784&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.ajo.2018.12.006","DOI":"10.1016\/j.ajo.2018.12.006"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"Leonardi\u00a0A, Messmer\u00a0EM, Labetoulle\u00a0M et al. Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies. Br J Ophthalmol 2019; 103: 125\u201331. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=29545413&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1136%2Fbjophthalmol-2017-311801","DOI":"10.1136\/bjophthalmol-2017-311801"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":[],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:32:42Z","timestamp":1781703162000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2019\/06\/klinisk-oversikt\/torre-oyne-diagnostikk-og-behandling"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,8]]},"references-count":15,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,8,20]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.18.0752","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,8]]}}}